Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins

Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, regulatory...

Full description

Saved in:

Bibliographic Details
Published in:	Oncotarget Vol. 7; no. 43; p. 70794
Main Authors:	Kumar, Nagi B, Pow-Sang, Julio, Spiess, Philippe E, Park, Jong, Salup, Raoul, Williams, Christopher R, Parnes, Howard, Schell, Michael J
Format:	Journal Article
Language:	English
Published:	United States 25.10.2016
Subjects:	Aged Aged, 80 and over Catechin - analogs & derivatives Catechin - therapeutic use Humans Liver Function Tests Male Middle Aged Placebos Prostatic Intraepithelial Neoplasia - prevention & control Prostatic Neoplasms - prevention & control Tea - chemistry Treatment Outcome green tea prostate cancer catechins safety
ISSN:	1949-2553, 1949-2553
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!